Exact Mass: 462.2267
Exact Mass Matches: 462.2267
Found 500 metabolites which its exact mass value is equals to given mass value 462.2267
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ST 25:5;O8
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Same as: D01442 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-Dehydrotestosterone glucuronide
6-Dehydrotestosterone glucuronide is a natural human metabolite of 6-dehydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
hydrocortisone hemisuccinate
Sar-Pro-Arg-pNA
SCHEMBL13960539
7-Acetoxybonducellpin C
8-O-(2-methylbutyryl)-dimerostemmolide-1-(5-hydroxyangelate)|8-O-<2-methylbutyryl>-dimerostemmolide-1-<5-hydroxyangelate>
16alpha-Acetoxy-19-O-acetyl-15-oxo-15,16-diydrohautriwasaeure-methylester
3beta,6beta-diangeloyloxy-8beta,10beta-dihydroxyeremophilenolide
claviridin C|methyl (4S,5Z,7E,12b,14Z,16R)-4,12-bis(acetyloxy)-16-hydroxy-9-oxoprosta-5,7,10,14-tetraen-1-oate
3beta-(2-methylbutanoyloxy)-8-beta-(2R,3R)-epoxyangeloyloxy-leptocarpin
1beta,8beta-dihydroxy-2beta,3alpha-diangeloyloxyeremophil-7(11)-en-8alpha(12)-olide
6Alpha,21-diacetoxy-11beta,17alpha-dihydroxypregn-4-ene-3,20-dione
7-O-deacetoxy-3-O-acetoxybonducellpin C|caesalpinin MF
Hydrocortisone hemisuccinate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
C25H34O8_beta-D-Glucopyranoside, 5-(4-hydroxyphenyl)-1-[2-(4-hydroxyphenyl)ethyl]pentyl
C25H34O8_1H-Furo[3,4-b]xanthene-9-propanoic acid, 3,5a,6,7,8,9,9a,10-octahydro-7-hydroxy-8-(1-hydroxy-1-methylethyl)-11-methoxy-4,5a,9-trimethyl-1-oxo-, (5aS,9R,9aR)
C25H34O8_1H-Furo[3,4-b]xanthene-9-propanoic acid, 3,5a,6,7,8,9,9a,10-octahydro-7-hydroxy-8-(1-hydroxy-1-methylethyl)-11-methoxy-4,5a,9-trimethyl-1-oxo
3-[7-hydroxy-8-(2-hydroxypropan-2-yl)-11-methoxy-4,5a,9-trimethyl-1-oxo-3,6,7,8,9a,10-hexahydro-[2]benzofuro[5,6-b]chromen-9-yl]propanoic acid
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
3-[7-hydroxy-8-(2-hydroxypropan-2-yl)-11-methoxy-4,5a,9-trimethyl-1-oxo-3,6,7,8,9a,10-hexahydro-[2]benzofuro[5,6-b]chromen-9-yl]propanoic acid_major
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_minor
methyl 4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate_major
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_78.3\\%
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol_80.4\\%
Ala His His Val
Ala His Val His
Ala Ile Met Glu
Ala Lys Met Asn
Ala Lys Asn Met
Ala Leu Glu Met
Ala Leu Met Glu
Ala Met Glu Leu
Ala Met Ile Glu
Ala Met Lys Asn
Ala Met Leu Glu
Ala Met Asn Lys
Ala Asn Lys Met
Ala Asn Met Lys
Ala Val His His
Cys Asp Ile Ile
Cys Asp Ile Leu
Cys Asp Leu Ile
Cys Asp Leu Leu
Cys Glu Ile Val
Cys Glu Val Ile
Cys Glu Val Leu
Cys Gly Lys Arg
Cys Gly Arg Lys
Cys Ile Asp Ile
Cys Ile Asp Leu
Cys Ile Glu Val
Cys Ile Ile Asp
Cys Ile Leu Asp
Cys Ile Val Glu
Cys Lys Gly Arg
Cys Lys Asn Val
Cys Lys Arg Gly
Cys Lys Val Asn
Cys Leu Asp Ile
Cys Leu Asp Leu
Cys Leu Glu Val
Cys Leu Ile Asp
Cys Leu Leu Asp
Cys Leu Val Glu
Cys Asn Lys Val
Cys Asn Val Lys
Cys Arg Gly Lys
Cys Arg Lys Gly
Cys Val Glu Ile
Cys Val Glu Leu
Cys Val Lys Asn
Cys Val Leu Glu
Cys Val Asn Lys
Asp Cys Ile Ile
Asp Cys Ile Leu
Asp Cys Leu Ile
Asp Cys Leu Leu
Asp Ile Cys Ile
Asp Ile Cys Leu
Asp Ile Ile Cys
Asp Ile Leu Cys
Asp Leu Cys Ile
Asp Leu Cys Leu
Asp Leu Ile Cys
Asp Leu Leu Cys
Asp Met Val Val
Asp Val Met Val
Asp Val Val Met
Glu Ala Ile Met
Glu Ala Leu Met
Glu Ala Met Ile
Glu Ala Met Leu
Glu Cys Ile Val
Glu Cys Leu Val
Glu Cys Val Ile
Glu Cys Val Leu
Glu Ile Ala Met
Glu Ile Cys Val
Glu Ile Met Ala
Glu Ile Thr Thr
Glu Ile Val Cys
Glu Leu Ala Met
Glu Leu Cys Val
Glu Leu Met Ala
Glu Leu Thr Thr
Glu Leu Val Cys
Glu Met Ala Ile
Glu Met Ile Ala
Glu Met Leu Ala
Glu Thr Ile Thr
Glu Thr Leu Thr
Glu Thr Thr Ile
Glu Thr Thr Leu
Glu Val Cys Ile
Glu Val Cys Leu
Glu Val Ile Cys
Glu Val Leu Cys
Gly Cys Lys Arg
Gly Cys Arg Lys
Gly His His Ile
Gly His His Leu
Gly His Ile His
Gly His Leu His
Gly Ile His His
Gly Lys Cys Arg
Gly Lys Met Gln
Gly Lys Gln Met
Gly Lys Arg Cys
Gly Leu His His
Gly Met Lys Gln
Gly Met Gln Lys
Gly Gln Lys Met
Gly Gln Met Lys
Gly Arg Cys Lys
Gly Arg Lys Cys
His Ala His Val
His Ala Val His
His Gly His Ile
His Gly His Leu
His Gly Ile His
His Gly Leu His
His His Ala Val
His His Gly Ile
His His Gly Leu
His His Ile Gly
His His Leu Gly
His His Val Ala
His Ile Gly His
His Ile His Gly
His Leu Gly His
His Leu His Gly
His Val Ala His
His Val His Ala
Ile Ala Glu Met
Ile Ala Met Glu
Ile Cys Asp Ile
Ile Cys Asp Leu
Ile Cys Glu Val
Ile Cys Ile Asp
Ile Cys Leu Asp
Ile Cys Val Glu
Ile Asp Cys Ile
Ile Asp Cys Leu
Ile Asp Ile Cys
Ile Asp Leu Cys
Ile Glu Ala Met
Ile Glu Cys Val
Ile Glu Met Ala
Ile Glu Thr Thr
Ile Glu Val Cys
Ile Gly His His
Ile His Gly His
Ile His His Gly
Ile Ile Cys Asp
Ile Ile Asp Cys
Ile Leu Cys Asp
Ile Leu Asp Cys
Ile Met Ala Glu
Ile Met Glu Ala
Ile Thr Glu Thr
Ile Thr Thr Glu
Ile Val Cys Glu
Ile Val Glu Cys
Lys Ala Met Asn
Lys Ala Asn Met
Lys Cys Gly Arg
Lys Cys Asn Val
Lys Cys Arg Gly
Lys Cys Val Asn
Lys Gly Cys Arg
Lys Gly Met Gln
Lys Gly Gln Met
Lys Gly Arg Cys
Lys Met Ala Asn
Lys Met Gly Gln
Lys Met Asn Ala
Lys Met Gln Gly
Lys Asn Ala Met
Lys Asn Cys Val
Lys Asn Met Ala
Lys Asn Val Cys
Lys Gln Gly Met
Lys Gln Met Gly
Lys Arg Cys Gly
Lys Arg Gly Cys
Lys Val Cys Asn
Lys Val Asn Cys
Leu Glu Thr Thr
Leu Glu Val Cys
Leu Gly His His
Leu His Gly His
Leu His His Gly
Leu Ile Cys Asp
Leu Ile Asp Cys
Leu Leu Cys Asp
Leu Leu Asp Cys
Leu Met Glu Ala
Leu Thr Glu Thr
Leu Thr Thr Glu
Leu Val Cys Glu
Leu Val Glu Cys
Met Ala Glu Ile
Met Ala Glu Leu
Met Ala Ile Glu
Met Ala Lys Asn
Met Ala Leu Glu
Met Ala Asn Lys
Met Asp Val Val
Met Glu Ala Ile
Met Glu Ala Leu
Met Glu Ile Ala
Met Glu Leu Ala
Met Gly Lys Gln
Met Gly Gln Lys
Met Ile Ala Glu
Met Ile Glu Ala
Met Lys Ala Asn
Met Lys Gly Gln
Met Lys Asn Ala
Met Lys Gln Gly
Met Leu Ala Glu
Met Leu Glu Ala
Met Asn Ala Lys
Met Asn Lys Ala
Met Gln Gly Lys
Met Gln Lys Gly
Met Val Asp Val
Met Val Val Asp
Asn Ala Lys Met
Asn Ala Met Lys
Asn Cys Lys Val
Asn Cys Val Lys
Asn Lys Ala Met
Asn Lys Cys Val
Asn Lys Met Ala
Asn Lys Val Cys
Asn Met Ala Lys
Asn Met Lys Ala
Asn Arg Ser Ser
Asn Ser Arg Ser
Asn Ser Ser Arg
Asn Val Cys Lys
Asn Val Lys Cys
Gln Gly Lys Met
Gln Gly Met Lys
Gln Lys Gly Met
Gln Lys Met Gly
Gln Met Gly Lys
Gln Met Lys Gly
Arg Cys Gly Lys
Arg Cys Lys Gly
Arg Gly Cys Lys
Arg Gly Lys Cys
Arg Lys Cys Gly
Arg Lys Gly Cys
Arg Asn Ser Ser
Arg Ser Asn Ser
Arg Ser Ser Asn
Ser Asn Arg Ser
Ser Asn Ser Arg
Ser Arg Asn Ser
Ser Arg Ser Asn
Ser Ser Asn Arg
Ser Ser Arg Asn
Thr Glu Ile Thr
Thr Glu Leu Thr
Thr Glu Thr Ile
Thr Glu Thr Leu
Thr Ile Glu Thr
Thr Ile Thr Glu
Thr Leu Glu Thr
Thr Leu Thr Glu
Thr Thr Glu Ile
Thr Thr Glu Leu
Thr Thr Ile Glu
Thr Thr Leu Glu
Val Ala His His
Val Cys Glu Ile
Val Cys Glu Leu
Val Cys Ile Glu
Val Cys Lys Asn
Val Cys Leu Glu
Val Cys Asn Lys
Val Asp Met Val
Val Asp Val Met
Val Glu Cys Ile
Val Glu Cys Leu
Val Glu Ile Cys
Val Glu Leu Cys
Val His Ala His
Val His His Ala
Val Ile Cys Glu
Val Ile Glu Cys
Val Lys Cys Asn
Val Lys Asn Cys
Val Leu Cys Glu
Val Leu Glu Cys
Val Met Asp Val
Val Met Val Asp
Val Asn Cys Lys
Val Asn Lys Cys
Val Val Asp Met
Val Val Met Asp
6-dehydrotestosterone O-glucuronide
Methyl 1,6-diacetoxy-7,11-dihydroxyabieta-8,11,13-trien-18-oate
Vistusertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes. Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes.
Urea, N-[3-methyl-6-[(4-methylphenyl)amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-(4-methylphenyl)- (9CI)
4-[2-chloroethyl(ethyl)amino]benzaldehyde,2,3-dihydro-1H-pyrrolo[1,2-a]benzimidazole,4-methylpyridine
5-[3-(3,5-Dimethyl-1,2,4-triazol-1-yl)-2-hydroxypropoxy]-2-methyl-1-(phenylmethyl)-3-indolecarboxylic acid ethyl ester
(1S,3S,5R,5aS,6S,7R,7S,9aR,10S,11S)-5a-(hydroxymethyl)-1,1,5,6,7,10-hexamethylspiro[2,9,12,13-tetraoxatetracyclo[8.2.1.01,5.07,11]tridecane-3,6-7,8,9,9a-tetrahydro-2-benzoxepine]-3,8-dione
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate
Arg-Lys-Cys-Gly
A tetrapeptide composed of L-arginine, L-lysine, L-cysteine, and glycine joined in sequence by peptide linkages.
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-N,11-N-dimethyl-6-oxo-12-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-N,11-N-dimethyl-6-oxo-12-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
methyl (2S,3S,3aR,9bR)-1-(cyclopentanecarbonyl)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylate
1,3-benzodioxol-5-yl-[(8S,9R,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9R,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9S,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9S,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9S,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9S,10S)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(1S)-2-benzoyl-1-(hydroxymethyl)-7-methoxy-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
methyl (2R,3R,3aS,9bS)-1-(cyclopentanecarbonyl)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylate
1,3-benzodioxol-5-yl-[(8R,9R,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9R,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9R,10S)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9S,10S)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9S,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9R,10S)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8R,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9S,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9S,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1,3-benzodioxol-5-yl-[(8S,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(1R)-2-benzoyl-1-(hydroxymethyl)-7-methoxy-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2,3-dihydroxypropyl [3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)
A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.
methyl 1,6-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-7-carboxylate
(3as,4s,5s,5ar,6r,9s,9as,9br)-6,9-dihydroxy-5a,9-dimethyl-5-{[(2e)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl (2e)-2-methylbut-2-enoate
5,17-dihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-8-yl 2-methylbutanoate
(1s,4e,9s,10s,11z,14r)-9-hydroxy-15-isopropyl-16-methoxy-1,4,11-trimethyl-7,17-dioxo-6,18-dioxatricyclo[12.4.0.0⁵,⁹]octadeca-4,11,15-trien-10-yl acetate
(1r,4s,5r,9s,10r,13r,14s,16s,19s,21s,23s,24s)-7-isopropyl-10,13-dimethyl-15,17,20,22-tetraoxaheptacyclo[12.10.0.0²,²¹.0⁵,¹³.0⁶,¹⁰.0¹⁶,²⁴.0¹⁹,²³]tetracosa-2,6-diene-4,9,23,24-tetrol
(1s,2r,3r,4s,5s,6s)-2,3,5-trihydroxy-4,6-dimethoxycyclohexyl 2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromene-6-carboxylate
16β-acetoxystrophanthidin
{"Ingredient_id": "HBIN001821","Ingredient_name": "16\u03b2-acetoxystrophanthidin","Alias": "NA","Ingredient_formula": "C25H34O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "281","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-acetoxybonducellpin c
{"Ingredient_id": "HBIN013020","Ingredient_name": "7-acetoxybonducellpin c","Alias": "NA","Ingredient_formula": "C25H34O8","Ingredient_Smile": "CC(=O)OC1CCC(C2(C1(C3CC4=C(C=CO4)C(C3C(C2)OC(=O)C)C(=O)OC)C)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "137","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}